VLTR-557

N/A

Report date: 2026/04/29 20:02:18

Base Information

Drug NameVLTR-557

Drug Alias NameVLTR-557

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody biopolymer conjugate (ABC)

Mechanisms of ActionVascular endothelial growth factor receptor antagonists

TargetsVascular endothelial growth factor receptor

Therapy Area/IndicationsWet age-related macular degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesValitor Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsWet age-related macular degeneration

Inactive IndicationsN/A

Other Information

ATC CodeN/A